Evolution of the Average Target: Repligen Corporation

Evolution of the Target Price: Repligen Corporation

Changes in Analyst Recommendations: Repligen Corporation

845d0e48ff0b9c8121ac210dc3a01065.f2uIO_QHL-IZYWSoJjMcz9PZApGAn5quwkGhb-qWlaE.TxLBQoBrYIsrEhPNUnRWiZWKUMjR2MjgunTXIJ7kxNMPHttXmmp6kHBSDw~5e39be2261dcaf30274b0ef2efab00ce
29/07 Repligen's Diversity of Growth Drivers Support Return to Mid-Teens Organic Sales Growth, RBC Says MT
29/07 RBC Raises Price Target on Repligen to $185 From $160, Keeps Outperform Rating MT
29/07 Deutsche Bank Adjusts Repligen Price Target to $200 From $180, Maintains Buy Rating MT
07/07 Benchmark Upgrades Repligen to Buy From Hold, Price Target is $185 MT
15/05 Repligen Likely to Benefit From Diverse Growth Factors, RBC Says MT
17/04 Rothschild & Co Redburn Initiates Repligen at Buy With $160 Price Target MT
25/02 UBS Adjusts Price Target on Repligen to $195 From $200, Maintains Buy Rating MT
16/01 UBS Adjusts Price Target on Repligen to $200 From $190, Maintains Buy Rating MT
01/25/01 HSBC Initiates Repligen at Buy With $150 Price Target MT
23/25/23 Repligen Shares Rise After Upgrade From Evercore ISI MT
22/25/22 Evercore ISI Upgrades Repligen to Outperform From In Line, Price Target is $155 MT
03/25/03 RBC Lifts Price Target on Repligen to $205 From $204, Keeps Outperform Rating MT
30/25/30 RBC Raises Price Target on Repligen to $204 From $193, Keeps Outperform Rating MT
29/25/29 Life sciences firm Repligen beats Q2 revenue estimates, raises full-year guidance RE
01/25/01 RBC Lifts Price Target on Repligen to $193 From $191, Keeps Outperform Rating MT
24/25/24 Barclays Initiates Repligen at Overweight With $150 Price Target MT
30/25/30 RBC Lowers Price Target on Repligen to $189 From $202, Keeps Outperform Rating MT
29/25/29 Wolfe Research Upgrades Repligen to Outperform From Peerperform MT
08/25/08 RBC Cuts Price Target on Repligen to $202 From $219, Keeps Outperform Rating MT
18/25/18 Evercore ISI Initiates Repligen at In Line With $155 Price Target MT
21/25/21 RBC Raises Price Target on Repligen to $205 From $203, Keeps Outperform Rating MT
21/25/21 Deutsche Bank Adjusts Repligen Price Target to $195 From $190, Maintains Buy Rating MT
10/25/10 TD Cowen Initiates Repligen at Buy With $200 Price Target MT
04/25/04 RBC Trims Price Target on Repligen to $203 From $207, Keeps Outperform Rating MT
09/24/09 RBC Lifts Price Target on Repligen to $207 From $205, Keeps Outperform Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+26.28%
+10.55%
+13.57%
+15.66%
+20.27%
+5.9%
+25.16%
+7.02%
+16.32%
+9.77%
Average +15.05%
Weighted average by Cap. +13.28%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
147.06USD
Average target price
185.70USD
Spread / Average Target
+26.27%
High Price Target
220.00USD
Spread / Highest target
+49.60%
Low Price Target
145.00USD
Spread / Lowest Target
-1.40%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

RBC Capital Markets
Deutsche Bank Securities
Benchmark Company
Rothschild & Co Redburn
UBS
HSBC
Evercore ISI
Barclays
Wolfe Research
TD Cowen
Guggenheim
KeyBanc Capital Markets
Craig-Hallum
JPMorgan Chase
Stephens Inc.
Wells Fargo Securities
Stifel Nicolaus
SVB Securities LLC
SVB Leerink
Exane BNP Paribas
William O'Neil & Co
HC Wainwright
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
147.06USD
Average target price
185.70USD
Spread / Average Target
+26.27%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RGEN Stock
  4. Consensus Repligen Corporation